Palermo, Italy

Giorgio Stassi

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Other. Active years: 2010.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal1 out of 834,307 
Other
 patents

Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Giorgio Stassi

Introduction

Giorgio Stassi is a notable inventor based in Palermo, Italy. He has made significant contributions to the field of cancer research through his innovative inventions. His work focuses on the modulation of cytokines to enhance the effectiveness of cancer treatments.

Latest Patents

One of Giorgio Stassi's key patents is titled "Sensitizing cells for apoptosis by selectively blocking cytokines." This invention involves the use of a cytokine antagonist that modulates the expression and function of Th2 helper cell cytokines. The primary goal of this invention is to down-regulate anti-apoptotic proteins in drug-resistant cancer cells, thereby sensitizing them for apoptosis. This breakthrough has the potential to improve treatment outcomes for patients with resistant forms of cancer.

Career Highlights

Throughout his career, Giorgio Stassi has worked with various organizations, including Apogenix GmbH. His research has been instrumental in advancing our understanding of cancer cell behavior and treatment resistance. His innovative approaches have garnered attention in the scientific community.

Collaborations

Giorgio has collaborated with several professionals in his field, including Matilde Todaro and Christian Gieffers. These collaborations have further enriched his research and contributed to the development of effective cancer therapies.

Conclusion

Giorgio Stassi's contributions to cancer research through his innovative patent demonstrate his commitment to improving treatment options for patients. His work continues to inspire advancements in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…